Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome

To examine the role of pro-inflammatory cytokines in ovarian hyperstimulation syndrome (OHSS). In vitro laboratory study of serum, peritoneal cells isolated and fluid obtained from ascites removed in the therapeutic management of four patients with OHSS. Tertiary care referral teaching hospital. Fou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 1993-11, Vol.60 (5), p.826-833
Hauptverfasser: Friedlander, Miriam A., de Mola, J. Ricardo Loret, Goldfarb, James M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 833
container_issue 5
container_start_page 826
container_title Fertility and sterility
container_volume 60
creator Friedlander, Miriam A.
de Mola, J. Ricardo Loret
Goldfarb, James M.
description To examine the role of pro-inflammatory cytokines in ovarian hyperstimulation syndrome (OHSS). In vitro laboratory study of serum, peritoneal cells isolated and fluid obtained from ascites removed in the therapeutic management of four patients with OHSS. Tertiary care referral teaching hospital. Four patients with OHSS comprised the study population. Five healthy women at the time of elective laparoscopic tubal ligation served as controls. Control serum was also obtained from healthy adult volunteers, and control peritoneal fluid (PF) was obtained from patients on peritoneal dialysis. Therapeutic paracentesis was performed on four patients with OHSS. Peritoneal cells were isolated and fluid obtained from ascites removed in the therapeutic management of the women with OHSS. Peritoneal cells were obtained by intraoperative lavage from the control women. The cells were incubated with various concentrations of Escherichia coli lipopolysaccharide (LPS) for 20 and 48hours. Interleukin-1/β (IL-1/β), tumor necrosis factor (TNF), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) were assayed in the incubation supernatants. The release of the three cytokines and PGE2 in response to LPS by peritoneal cells from women with OHSS was not different from the controls. However, both serum and ascitic fluid from women with OHSS contained significantly greater levels of IL-6 than control serum and PF. No significant differences in TNF levels in serum, ascitic fluid, or PF could be found by ELISA or bioassay. Increased production of IL-6, released into the peritoneal cavity and the circulation, may mediate OHSS.
doi_str_mv 10.1016/S0015-0282(16)56283-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76024987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028216562839</els_id><sourcerecordid>76024987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-ff218e02d6a9e819052fdedb17eb194db93f9a5463a3c2a7be0523678ac3c75d3</originalsourceid><addsrcrecordid>eNqFkE1rFTEUhoMo9bb6EwpZiOhiNB-TTLKSUmoVCi7UdcgkZ2x0JrkmmVvuvzftvdytq8PLec4HD0KXlHyghMqP3wmhoiNMsXdUvheSKd7pZ2hDhZCdkII_R5sT8hKdl_KbECLpwM7QmWKsZ1Jt0K-bGXa2gsetwlxwmnCIFfIM658QO9kStsWFCgXb6HGBvC54ymnBD2mBiB9CvcdpZ3OwEd_vt5BLDcs62xpSxGUffWPhFXox2bnA62O9QD8_3_y4_tLdfbv9en1117mey9pNE6MKCPPSalBUE8EmD36kA4xU937UfNJW9JJb7pgdRmgEl4OyjrtBeH6B3h72bnP6u0KpZgnFwTzbCGktZpCE9VoNDRQH0OVUSobJbHNYbN4bSsyjYPMk2DzaMy09CTa6zV0eD6zjAv40dTTa-m-O_WbNzlO20YVywvighGa8YZ8OWHMOuwDZNMcQHfiQwVXjU_jPI_8A1bSZMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76024987</pqid></control><display><type>article</type><title>Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Friedlander, Miriam A. ; de Mola, J. Ricardo Loret ; Goldfarb, James M.</creator><creatorcontrib>Friedlander, Miriam A. ; de Mola, J. Ricardo Loret ; Goldfarb, James M.</creatorcontrib><description>To examine the role of pro-inflammatory cytokines in ovarian hyperstimulation syndrome (OHSS). In vitro laboratory study of serum, peritoneal cells isolated and fluid obtained from ascites removed in the therapeutic management of four patients with OHSS. Tertiary care referral teaching hospital. Four patients with OHSS comprised the study population. Five healthy women at the time of elective laparoscopic tubal ligation served as controls. Control serum was also obtained from healthy adult volunteers, and control peritoneal fluid (PF) was obtained from patients on peritoneal dialysis. Therapeutic paracentesis was performed on four patients with OHSS. Peritoneal cells were isolated and fluid obtained from ascites removed in the therapeutic management of the women with OHSS. Peritoneal cells were obtained by intraoperative lavage from the control women. The cells were incubated with various concentrations of Escherichia coli lipopolysaccharide (LPS) for 20 and 48hours. Interleukin-1/β (IL-1/β), tumor necrosis factor (TNF), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) were assayed in the incubation supernatants. The release of the three cytokines and PGE2 in response to LPS by peritoneal cells from women with OHSS was not different from the controls. However, both serum and ascitic fluid from women with OHSS contained significantly greater levels of IL-6 than control serum and PF. No significant differences in TNF levels in serum, ascitic fluid, or PF could be found by ELISA or bioassay. Increased production of IL-6, released into the peritoneal cavity and the circulation, may mediate OHSS.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/S0015-0282(16)56283-9</identifier><identifier>PMID: 8224268</identifier><identifier>CODEN: FESTAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; ascites ; Ascites - metabolism ; Biological and medical sciences ; Biomarkers - analysis ; Biomarkers - blood ; Birth control ; Danazol - therapeutic use ; Endometriosis - blood ; Endometriosis - drug therapy ; Endometriosis - metabolism ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Infertility, Female - blood ; Infertility, Female - metabolism ; interleukin-1 ; interleukin-6 ; Interleukin-6 - analysis ; Interleukin-6 - blood ; Medical sciences ; Ovarian hyperstimulation syndrome ; Ovarian Hyperstimulation Syndrome - blood ; Ovarian Hyperstimulation Syndrome - metabolism ; prostaglandin E2 ; Sterility. Assisted procreation ; tumor necrosis factor</subject><ispartof>Fertility and sterility, 1993-11, Vol.60 (5), p.826-833</ispartof><rights>1993 American Society for Reproductive Medicine</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-ff218e02d6a9e819052fdedb17eb194db93f9a5463a3c2a7be0523678ac3c75d3</citedby><cites>FETCH-LOGICAL-c436t-ff218e02d6a9e819052fdedb17eb194db93f9a5463a3c2a7be0523678ac3c75d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028216562839$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3785923$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8224268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Friedlander, Miriam A.</creatorcontrib><creatorcontrib>de Mola, J. Ricardo Loret</creatorcontrib><creatorcontrib>Goldfarb, James M.</creatorcontrib><title>Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>To examine the role of pro-inflammatory cytokines in ovarian hyperstimulation syndrome (OHSS). In vitro laboratory study of serum, peritoneal cells isolated and fluid obtained from ascites removed in the therapeutic management of four patients with OHSS. Tertiary care referral teaching hospital. Four patients with OHSS comprised the study population. Five healthy women at the time of elective laparoscopic tubal ligation served as controls. Control serum was also obtained from healthy adult volunteers, and control peritoneal fluid (PF) was obtained from patients on peritoneal dialysis. Therapeutic paracentesis was performed on four patients with OHSS. Peritoneal cells were isolated and fluid obtained from ascites removed in the therapeutic management of the women with OHSS. Peritoneal cells were obtained by intraoperative lavage from the control women. The cells were incubated with various concentrations of Escherichia coli lipopolysaccharide (LPS) for 20 and 48hours. Interleukin-1/β (IL-1/β), tumor necrosis factor (TNF), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) were assayed in the incubation supernatants. The release of the three cytokines and PGE2 in response to LPS by peritoneal cells from women with OHSS was not different from the controls. However, both serum and ascitic fluid from women with OHSS contained significantly greater levels of IL-6 than control serum and PF. No significant differences in TNF levels in serum, ascitic fluid, or PF could be found by ELISA or bioassay. Increased production of IL-6, released into the peritoneal cavity and the circulation, may mediate OHSS.</description><subject>Adult</subject><subject>ascites</subject><subject>Ascites - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - analysis</subject><subject>Biomarkers - blood</subject><subject>Birth control</subject><subject>Danazol - therapeutic use</subject><subject>Endometriosis - blood</subject><subject>Endometriosis - drug therapy</subject><subject>Endometriosis - metabolism</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Infertility, Female - blood</subject><subject>Infertility, Female - metabolism</subject><subject>interleukin-1</subject><subject>interleukin-6</subject><subject>Interleukin-6 - analysis</subject><subject>Interleukin-6 - blood</subject><subject>Medical sciences</subject><subject>Ovarian hyperstimulation syndrome</subject><subject>Ovarian Hyperstimulation Syndrome - blood</subject><subject>Ovarian Hyperstimulation Syndrome - metabolism</subject><subject>prostaglandin E2</subject><subject>Sterility. Assisted procreation</subject><subject>tumor necrosis factor</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1rFTEUhoMo9bb6EwpZiOhiNB-TTLKSUmoVCi7UdcgkZ2x0JrkmmVvuvzftvdytq8PLec4HD0KXlHyghMqP3wmhoiNMsXdUvheSKd7pZ2hDhZCdkII_R5sT8hKdl_KbECLpwM7QmWKsZ1Jt0K-bGXa2gsetwlxwmnCIFfIM658QO9kStsWFCgXb6HGBvC54ymnBD2mBiB9CvcdpZ3OwEd_vt5BLDcs62xpSxGUffWPhFXox2bnA62O9QD8_3_y4_tLdfbv9en1117mey9pNE6MKCPPSalBUE8EmD36kA4xU937UfNJW9JJb7pgdRmgEl4OyjrtBeH6B3h72bnP6u0KpZgnFwTzbCGktZpCE9VoNDRQH0OVUSobJbHNYbN4bSsyjYPMk2DzaMy09CTa6zV0eD6zjAv40dTTa-m-O_WbNzlO20YVywvighGa8YZ8OWHMOuwDZNMcQHfiQwVXjU_jPI_8A1bSZMg</recordid><startdate>19931101</startdate><enddate>19931101</enddate><creator>Friedlander, Miriam A.</creator><creator>de Mola, J. Ricardo Loret</creator><creator>Goldfarb, James M.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19931101</creationdate><title>Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome</title><author>Friedlander, Miriam A. ; de Mola, J. Ricardo Loret ; Goldfarb, James M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-ff218e02d6a9e819052fdedb17eb194db93f9a5463a3c2a7be0523678ac3c75d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>ascites</topic><topic>Ascites - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - analysis</topic><topic>Biomarkers - blood</topic><topic>Birth control</topic><topic>Danazol - therapeutic use</topic><topic>Endometriosis - blood</topic><topic>Endometriosis - drug therapy</topic><topic>Endometriosis - metabolism</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Infertility, Female - blood</topic><topic>Infertility, Female - metabolism</topic><topic>interleukin-1</topic><topic>interleukin-6</topic><topic>Interleukin-6 - analysis</topic><topic>Interleukin-6 - blood</topic><topic>Medical sciences</topic><topic>Ovarian hyperstimulation syndrome</topic><topic>Ovarian Hyperstimulation Syndrome - blood</topic><topic>Ovarian Hyperstimulation Syndrome - metabolism</topic><topic>prostaglandin E2</topic><topic>Sterility. Assisted procreation</topic><topic>tumor necrosis factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Friedlander, Miriam A.</creatorcontrib><creatorcontrib>de Mola, J. Ricardo Loret</creatorcontrib><creatorcontrib>Goldfarb, James M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Friedlander, Miriam A.</au><au>de Mola, J. Ricardo Loret</au><au>Goldfarb, James M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>1993-11-01</date><risdate>1993</risdate><volume>60</volume><issue>5</issue><spage>826</spage><epage>833</epage><pages>826-833</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><coden>FESTAS</coden><abstract>To examine the role of pro-inflammatory cytokines in ovarian hyperstimulation syndrome (OHSS). In vitro laboratory study of serum, peritoneal cells isolated and fluid obtained from ascites removed in the therapeutic management of four patients with OHSS. Tertiary care referral teaching hospital. Four patients with OHSS comprised the study population. Five healthy women at the time of elective laparoscopic tubal ligation served as controls. Control serum was also obtained from healthy adult volunteers, and control peritoneal fluid (PF) was obtained from patients on peritoneal dialysis. Therapeutic paracentesis was performed on four patients with OHSS. Peritoneal cells were isolated and fluid obtained from ascites removed in the therapeutic management of the women with OHSS. Peritoneal cells were obtained by intraoperative lavage from the control women. The cells were incubated with various concentrations of Escherichia coli lipopolysaccharide (LPS) for 20 and 48hours. Interleukin-1/β (IL-1/β), tumor necrosis factor (TNF), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) were assayed in the incubation supernatants. The release of the three cytokines and PGE2 in response to LPS by peritoneal cells from women with OHSS was not different from the controls. However, both serum and ascitic fluid from women with OHSS contained significantly greater levels of IL-6 than control serum and PF. No significant differences in TNF levels in serum, ascitic fluid, or PF could be found by ELISA or bioassay. Increased production of IL-6, released into the peritoneal cavity and the circulation, may mediate OHSS.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8224268</pmid><doi>10.1016/S0015-0282(16)56283-9</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 1993-11, Vol.60 (5), p.826-833
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_76024987
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
ascites
Ascites - metabolism
Biological and medical sciences
Biomarkers - analysis
Biomarkers - blood
Birth control
Danazol - therapeutic use
Endometriosis - blood
Endometriosis - drug therapy
Endometriosis - metabolism
Female
Gynecology. Andrology. Obstetrics
Humans
Infertility, Female - blood
Infertility, Female - metabolism
interleukin-1
interleukin-6
Interleukin-6 - analysis
Interleukin-6 - blood
Medical sciences
Ovarian hyperstimulation syndrome
Ovarian Hyperstimulation Syndrome - blood
Ovarian Hyperstimulation Syndrome - metabolism
prostaglandin E2
Sterility. Assisted procreation
tumor necrosis factor
title Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T20%3A48%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20levels%20of%20interleukin-6%20in%20ascites%20and%20serum%20from%20women%20with%20ovarian%20hyperstimulation%20syndrome&rft.jtitle=Fertility%20and%20sterility&rft.au=Friedlander,%20Miriam%20A.&rft.date=1993-11-01&rft.volume=60&rft.issue=5&rft.spage=826&rft.epage=833&rft.pages=826-833&rft.issn=0015-0282&rft.eissn=1556-5653&rft.coden=FESTAS&rft_id=info:doi/10.1016/S0015-0282(16)56283-9&rft_dat=%3Cproquest_cross%3E76024987%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76024987&rft_id=info:pmid/8224268&rft_els_id=S0015028216562839&rfr_iscdi=true